TTLTicker Tales

Vishal Nirmiti

Maker of pre-stressed concrete railway sleepers and MS pipes for hydro projects, also offering railway EPC services.

Archived
Neutral

Last updated 16 Oct 2026, 3:16 pm IST

Price band
₹208 – ₹220
Lot size
68
Issue size
₹178 Cr (₹145 Cr fresh + ₹33 Cr OFS)
Opens
30 Sept 2026
Closes
5 Oct 2026
Exchange
Both

The numbers

GMP
₹4-20 (~2-9%) (5 Oct, final day; sources conflict)
Subscription
~1.2-1.7× (5 Oct, final; sources differ)
Listed at (NSE)
−2.3%
Day-1 close
−7.2%
Listing date
8 Oct 2026
Model prediction
~flat expected -> Neutral. Listed -2.3% NSE (8 Oct), closed -7.2%; call held.

The Ticker Tales take

Vishal Nirmiti makes pre-stressed concrete sleepers for railways and steel pipes for hydro projects, and also does railway infrastructure contracting. Most of the ₹178 crore issue is fresh shares (₹145 crore) with a smaller ₹33 crore of existing owners selling, and the bulk is reserved for retail investors. Worth weighing: FY26 revenue and profit both grew only about 6%, to ₹344 crore and ₹25 crore, and the business leans on railway orders. Demand is very quiet: on day two the book was only about 0.23 times covered (big investors usually bid late), and the grey market premium is thin at about ₹6, roughly 3% over the top of the band. That sits inside our flat zone, so this is a Neutral. It listed at ₹215 on NSE, down 2.3% against our flat call, and closed about -7.2% — weaker than expected, though the Neutral call correctly signalled no edge.

More details

Sector
Railway sleepers / EPC
FY26 PAT
₹24.98 Cr (+6%)
Registrar
MUFG Intime India
Issue type
Book-built (₹145 Cr fresh + ₹33 Cr OFS)
Reservation
QIB 1% / Retail 70% / NII 29%
FY26 revenue
₹344.13 Cr (+6%)
Lead manager
Saffron Capital Advisors
Anil Singhvi - Long-term call
Not clearly stated
Anil Singhvi - Listing-gain call
Not clearly stated
Share this X LinkedIn WhatsApp

Want a heads-up when a new IPO opens?

We'll email you when one opens — and only then.

No spam, ever. Leave whenever you like.

Calls here follow a set formula (GMP, subscription trends) plus Anil Singhvi's publicly shared view — not investment advice. Please do your own research before investing.